News

Brandon is the Director of Miami at Venture For America (VFA), a non-profit organization that creates economic opportunity in American cities by mobilizing the next generation of entrepreneurs and equipping them with the skills and resources they need to create...

NTM Info & Research Welcomes Attorney and Rare Disease Advocate, Candace Lerman to Board of Directors NTM Info & Research (NTMir) is pleased to announce the appointment of Candace Lerman, Esq. to the Board of Directors. Ms. Lerman is an attorney, consultant, and...

NTM Info & Research (NTMir) is pleased to announce the appointment of Candace Lerman, Esq. to the Board of Directors. Ms. Lerman is an attorney and author of the rare disease blog, RareCandace.com. Currently she is US Corporate Attorney at Avheris Health. She...

NTM Info & Research Awards Grant to Oregon Health & Science University Study Will Assess Efficacy of Hypertonic Saline in Treatment of Pulmonary NTM Disease CORAL GABLES, FL, November 24, 2020 – NTM Info & Research (NTMir), the national nonprofit organization...

NTM Info & Research Welcomes Brandon Mitchell Chair of the Board of Directors Brandon is the Director of Miami at Venture For America (VFA), a non-profit organization that creates economic opportunity in American cities by mobilizing the next generation of...

NTM Info & Research partnered with the National Organization for Rare Disorders (NORD) to help publish a Physician Guide to Nontuberculous Mycobacterial Lung Disease. The guide, which was authored by Dr. Leah Lande, is designed to help promote awareness of NTM...

We are saddened by the news that Dr. Michael Iseman has passed away at the age of 83. Dr. Iseman served for many years as the Chief of the Division of Mycobacterial and Respiratory Infections at National Jewish Health and remains widely regarded as a pioneer and...

ARIKAYCE® is currently the only FDA approved drug designed specifically for NTM (MAC) and now available through prescription from your physician for treatment of refractory MAC lung infection in adult patients. This medication is only available through select...

by Amy Leitman   At the end of June I attended DIA 2016, the annual conference for the Drug Information Association, as part of their Patient Advocacy Fellowship Program. The Fellowship Program is a major initiative designed to build industry awareness of the...

Every day, NTM Info & Research’s commitment to finding therapies serves as hope for the NTM community. We are constantly looking for ways to boost our financial support of research to achieve better treatments and, eventually, a cure. Until that cure is found,...